Related Experiment Video
Updated: Nov 20, 2025

07:27
Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
25.0K
Two Challenging Cases with COVID heart
Sanaz Asadian1, Leila Hosseini1,2, Mohsen Maadani1
1Rajaie Cardiovascular Medical and Research Center Iran University of Medical Sciences Tehran Iran.
Clinical Case Reports
|January 25, 2021
Summary
COVID-19 can harm the heart by increasing blood clots, potentially causing heart attacks. This risk exists even for individuals without prior heart conditions.
Area of Science:
- Cardiology
- Infectious Diseases
- Pathophysiology
Background:
- The novel coronavirus disease (COVID-19) has emerged as a significant global health threat.
- Understanding the cardiovascular implications of COVID-19 is crucial for patient management and outcomes.
Observation:
- COVID-19 impacts cardiac health through multiple mechanisms.
- The virus can trigger pro-thrombotic states, elevating the risk of cardiovascular events.
Findings:
- SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) infection is associated with an increased incidence of thrombotic complications.
- These thrombotic events can precipitate myocardial infarction (MI), or heart attack, even in individuals without pre-existing cardiovascular disease.
Implications:
- The findings highlight the importance of monitoring cardiac function in COVID-19 patients.
- Early recognition and management of thrombotic risks are essential to prevent myocardial infarction and improve survival rates in COVID-19 survivors.
More Related Videos
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
151
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
151
Cardiomyopathy III: Hypertrophic Cardiomyopathy
148
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
148
Cardiomyopathy V: Interprofessional Care
124
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
124
Heart Failure III: Clinical Manifestations
150
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
150
Imbalances in Cardiac Output
1.9K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.9K
Coronary Artery Disease III: Clinical Manifestations
149
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
149

